Search
Search
About
Log in
Join
Experiences with
Enzalutamide
Posts
Communities
833 public posts
Filter results
Advice for Actinum Lu177 patient
No chemo, only Lupron and
Enzalutamide
(stopped the latter when quickly became castrate resistant).
No chemo, only Lupron and
Enzalutamide
(stopped the latter when quickly became castrate resistant).
Sriyantra
in
Advanced Prostate Cancer
6 years ago
Teddyb2
Does anyone have any experience of abiraterone or
enzalutamide
?
Does anyone have any experience of abiraterone or
enzalutamide
?
Teddyb2
in
Advanced Prostate Cancer
6 years ago
Please shoot holes in this plan.
Dx Stage 4 Gl 9 bone mets only, PSA 41, 6 cy. docataxel, leuprolide since 10/16, PSA 1.2, doubled in a year, added bicalutamide, doubled in a year, swapped out Casodex for
enzalutamide
, roughly half way through the Provenge thang.
Dx Stage 4 Gl 9 bone mets only, PSA 41, 6 cy. docataxel, leuprolide since 10/16, PSA 1.2, doubled in a year, added bicalutamide, doubled in a year, swapped out Casodex for
enzalutamide
, roughly half way through the Provenge thang.
Crabcrushe
in
Advanced Prostate Cancer
6 years ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
First time clinical trial-open study.Pembrolizumab and olaparib.Pembrolizumab and enzalutamide
Any one had any experience with these drugs .I am Gleason 4+3.Diagnosed 2007,asymptomatic .PSA now 1.7 but rising .on Zytiga 13 months now .
Any one had any experience with these drugs .I am Gleason 4+3.Diagnosed 2007,asymptomatic .PSA now 1.7 but rising .on Zytiga 13 months now .
donovan0932
in
Advanced Prostate Cancer
6 years ago
Drug Effective in 80% of Men With BRCA-mutant Prostate Cancer
All had progressed on ADT; 99% were post-docetaxel, 90% post-abiraterone/
enzalutamide
, 38% post-cabazitaxel. The overall RR was 54% (95%CI 39-69%, meeting threshold for primary endpoint) in the 400mg cohort and 37% (95%CI 23-53%) in the 300mg cohort.
All had progressed on ADT; 99% were post-docetaxel, 90% post-abiraterone/
enzalutamide
, 38% post-cabazitaxel. The overall RR was 54% (95%CI 39-69%, meeting threshold for primary endpoint) in the 400mg cohort and 37% (95%CI 23-53%) in the 300mg cohort.
pjoshea13
in
Advanced Prostate Cancer
5 years ago
Darolutamide
ODM-201 is a full and high-affinity AR antagonist that, similar to second-generation antiandrogens
enzalutamide
and ARN-509, inhibits testosterone-induced nuclear translocation of AR.
ODM-201 is a full and high-affinity AR antagonist that, similar to second-generation antiandrogens
enzalutamide
and ARN-509, inhibits testosterone-induced nuclear translocation of AR.
pjoshea13
in
Advanced Prostate Cancer
6 years ago
Wondering what is next?
PSA rising slightly so put on zXtandi (
Enzalutamide
) still on Lupron, Zometa. Stopped eating about 3 weeks after going on Enz says everything tastes awful and really salty. Lost 12 lbs in 15 days finally have the weight loss under control with Boost still doesn’t eat much.
PSA rising slightly so put on zXtandi (
Enzalutamide
) still on Lupron, Zometa. Stopped eating about 3 weeks after going on Enz says everything tastes awful and really salty. Lost 12 lbs in 15 days finally have the weight loss under control with Boost still doesn’t eat much.
Kobina
in
Advanced Prostate Cancer
5 years ago
Phase 3 ARCHES trial - Enzalutamide + ADT
) capsules XTANDI (
enzalutamide
) is an androgen receptor inhibitor indicated for the treatment of patients with castration-resistant prostate cancer.
) capsules XTANDI (
enzalutamide
) is an androgen receptor inhibitor indicated for the treatment of patients with castration-resistant prostate cancer.
pjoshea13
in
Advanced Prostate Cancer
6 years ago
Prednisone to Blame for ERA 223 Trial Failure?
The randomized open-label trial is assessing whether upfront use of a combination of
enzalutamide
plus radium-223 improves radiographic PFS compared with
enzalutamide
alone in men with asymptomatic or mildly symptomatic CRPC patients with bone metastases.
The randomized open-label trial is assessing whether upfront use of a combination of
enzalutamide
plus radium-223 improves radiographic PFS compared with
enzalutamide
alone in men with asymptomatic or mildly symptomatic CRPC patients with bone metastases.
pjoshea13
in
Advanced Prostate Cancer
6 years ago
Why I'm here Part 2
Dumb, but I ain't got time to dwell\snivel about the past, so when the the bicalutamide failed after about a year and the good Doctor offered the Provenge, I was on it like a duck on a June bug and requested the
enzalutamide
.
Dumb, but I ain't got time to dwell\snivel about the past, so when the the bicalutamide failed after about a year and the good Doctor offered the Provenge, I was on it like a duck on a June bug and requested the
enzalutamide
.
Crabcrushe
in
Advanced Prostate Cancer
6 years ago
Carboplatin without a test
With a stage 4/G9 w/bone mets only in '16 and enjoying leuprolide/
enzalutamide
after docatexel (6 in '16), I'd think Carboplat would be a no-brainer. Avodart, as well. What hoops are there? Crabcrusher
With a stage 4/G9 w/bone mets only in '16 and enjoying leuprolide/
enzalutamide
after docatexel (6 in '16), I'd think Carboplat would be a no-brainer. Avodart, as well. What hoops are there? Crabcrusher
Crabcrushe
in
Advanced Prostate Cancer
6 years ago
Niclosamide and Bicalutamide CombinationTreatment Overcomes Enzalutamide- andBicalutamide-Resistant Prostate Cancer
Furthermore, combination of niclosamide with bicalutamide inhibits
enzalutamide
-resistant tumor growth, suggesting that the combination of niclosamide with bicalutamide could provide a potential cost-effective strategy to treat advanced prostate cancer that fails to respond to
enzalutamide
therapy.
Furthermore, combination of niclosamide with bicalutamide inhibits
enzalutamide
-resistant tumor growth, suggesting that the combination of niclosamide with bicalutamide could provide a potential cost-effective strategy to treat advanced prostate cancer that fails to respond to
enzalutamide
therapy.
traveller64
in
Advanced Prostate Cancer
6 years ago
Enzalutamide plus BIRM any conflict?
For the past 32 monthsI have been on 3 monthly ADT injections of Triptorilin and I had 6 infusions of Docetaxel. 17 months ago I started
Enzalutamide
My PSA at diagnosis was 78 but since starting
Enzalutamide
has been <0.1. I used to walk a lot but the constant fatigue has been getting me down.
For the past 32 monthsI have been on 3 monthly ADT injections of Triptorilin and I had 6 infusions of Docetaxel. 17 months ago I started
Enzalutamide
My PSA at diagnosis was 78 but since starting
Enzalutamide
has been <0.1. I used to walk a lot but the constant fatigue has been getting me down.
cromone
in
Advanced Prostate Cancer
6 years ago
Wanted to share some positive news
PSA started to rise quickly and he started
Enzalutamide
in Jan 2018, within a month PSA had dropped to 0.1 and has stayed there, latest PSA today still >0.1. No side effects, no pain, a little fatigue, but still very active.
PSA started to rise quickly and he started
Enzalutamide
in Jan 2018, within a month PSA had dropped to 0.1 and has stayed there, latest PSA today still >0.1. No side effects, no pain, a little fatigue, but still very active.
LB100
in
Advanced Prostate Cancer
6 years ago
Thoughts on BAT
So far, most trials have involved patients who had failed ADT 1 (Zolodex, Lupron) and the second order antiandrogens like
Enzalutamide
and Abiraterone. So they were in the context of evident resistance against Abi and Enza shown by rising PSA (and I think shortening doubling times).
So far, most trials have involved patients who had failed ADT 1 (Zolodex, Lupron) and the second order antiandrogens like
Enzalutamide
and Abiraterone. So they were in the context of evident resistance against Abi and Enza shown by rising PSA (and I think shortening doubling times).
kaptank
in
Advanced Prostate Cancer
6 years ago
Darolutamide ARAMIS study.
, Poster Session A: Prostate Cancer and Trials in Progress, Oral Abstract Session A: Prostate Cancer Date: Thursday, February 14: 11:30 AM-1:00 PM PST and 5:30-6:30 PM PST (poster presentation), 1:45-1:55 PM PST (oral presentation) Higher blood-brain barrier penetration of [14C]apalutamide and [14C]
enzalutamide
, Poster Session A: Prostate Cancer and Trials in Progress, Oral Abstract Session A: Prostate Cancer Date: Thursday, February 14: 11:30 AM-1:00 PM PST and 5:30-6:30 PM PST (poster presentation), 1:45-1:55 PM PST (oral presentation) Higher blood-brain barrier penetration of [14C]apalutamide and [14C]
enzalutamide
pjoshea13
in
Advanced Prostate Cancer
6 years ago
5 years journey for QOL
I would have also liked to try Deithylstilbestrol intermittently at low dose https://onlinelibrary.wiley.com/doi/full/10.1111/j.1464-410X.2012.11206.x I added oestrogen patches to
Enzalutamide
after it stopped working and his PSA dropped 14 % in 10 days .
I would have also liked to try Deithylstilbestrol intermittently at low dose https://onlinelibrary.wiley.com/doi/full/10.1111/j.1464-410X.2012.11206.x I added oestrogen patches to
Enzalutamide
after it stopped working and his PSA dropped 14 % in 10 days .
mijnzoek
in
Advanced Prostate Cancer
6 years ago
Castration sensitive vs castate resistant
My husbands PSA became resistant to Casodex/Lupron but he is currently responding to
Enzalutamide
/ Lupron. Does this mean he qualifies as hormone sensitive or as hormone resistant?
My husbands PSA became resistant to Casodex/Lupron but he is currently responding to
Enzalutamide
/ Lupron. Does this mean he qualifies as hormone sensitive or as hormone resistant?
Blair77
in
Advanced Prostate Cancer
6 years ago
My Journey so far since diagnosis of prostate cancer
When it went out of range I was prescribed
enzalutamide
and this worked for about 6 months keeping things in check. However the PSA has now risen again to 34 and the cancer is more advanced in my bones , particularly the right iliac bone.
When it went out of range I was prescribed
enzalutamide
and this worked for about 6 months keeping things in check. However the PSA has now risen again to 34 and the cancer is more advanced in my bones , particularly the right iliac bone.
Muirk1960
in
Advanced Prostate Cancer
6 years ago
Update on PARP inhibitors
MO cancelled Cycle 10 and put me on
Enzalutamide
. 3 months later PSA had risen to 15.1 (Sep 2018, no impact at all on PSADT) so MO discontinued Enza. I was then enrolled in PARP inhibitor trial (niraparib).
MO cancelled Cycle 10 and put me on
Enzalutamide
. 3 months later PSA had risen to 15.1 (Sep 2018, no impact at all on PSADT) so MO discontinued Enza. I was then enrolled in PARP inhibitor trial (niraparib).
Hazard
in
Advanced Prostate Cancer
6 years ago
1
...
33
34
35
...
42
Next page
10
20
30
40
Filter results
Clear filters
Posted in
All communities
Advanced Prostate Cancer
760 results
Fight Prostate Cancer
56 results
Prostate Cancer Network
7 results
View top 10 communities
Sort by
Most Relevant
Newest